LCI snaps up Pfizer’s manufacturing facility

MG News | September 09, 2024 at 09:24 AM GMT+05:00

0:00

September 09, 2024 (MLN): Marking a significant expansion in LCI's pharmaceutical footprint, Lucky Core Industries Limited (PSX: LCI) has acquired Pfizer Pakistan Limited's manufacturing facility under the Asset Purchase Agreements entered into between the parties.

Along with this, the company has also acquired the products and product registrations consisting of Ansaid, Ponstan, Ponstan Forte, Basoquin, Deltacortril, Lysovit, Corex-D and Mycitracin.

In addition to this trademarks associated with the said pharmaceutical products either through an outright assignment of trademarks or a perpetual license to use the relevant trademarks from relevant Pfizer group entities have also been acquired.

Copyright Mettis Link News

Related News

Name	Price/Vol	%Chg/NChg
KSE100	169,129.06 80.47M	0.43% 716.82
ALLSHR	101,246.55 179.57M	0.40% 405.40
KSE30	51,152.70 14.78M	0.32% 162.22
KMI30	243,134.86 44.82M	0.54% 1300.70
KMIALLSHR	65,710.64 109.88M	0.60% 390.26
BKTi	47,422.38 8.05M	0.17% 81.58
OGTi	35,013.29 0.49M	0.21% 73.34

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	77,720.00	77,890.00 76,485.00	1060.00 1.38%
BRENT CRUDE	111.19	111.96 110.26	-0.07 -0.06%
RICHARDS BAY COAL MONTHLY	109.50	110.00 109.00	2.40 2.24%
ROTTERDAM COAL MONTHLY	104.75	106.75 104.75	0.45 0.43%
USD RBD PALM OLEIN	1,191.50	1,191.50 1,191.50	0.00 0.00%
CRUDE OIL - WTI	99.35	100.74 98.42	-0.58 -0.58%
SUGAR #11 WORLD	14.24	14.30 13.98	0.27 1.93%